Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07398443

Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults

The multi session experimental study aims to determine dual use patterns of marijuana and tobacco by assessing the impact of price and availability of marijuana and tobacco using a cross price elasticity of demand task. The study will recruit 120 non-treatment seeking emerging young adults (18-25 years) who smoke marijuana and tobacco.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–25 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Brown University School of Public Health

Providence, Rhode Island, 02903, United States

Location status: Recruiting

Location contact

Elizabeth Aston, PhD

CONTACT

[email protected]

401-863-6668

About this study

Young adulthood is a crucial time to study substance use disorders which increase cancer risk later in life. It is especially important to understand marijuana and tobacco use as most young adults often use both. Although dual use is related with increased long-term health and behavioral risks, underlying behavioral mechanisms remain unclear. This study aims to address this gap by using rigorous laboratory-based behavioral economic measure including a novel cross-price elasticity of demand (CPED) task and an innovative extension of cue-induced demand to assess cross-cue reactivity to better understand co- use. The results will help lead cessation efforts in this population and reduce cancer risk across the lifespan. Participants (N = 120) will be young adults (age 18-25) endorsing current tobacco and marijuana use and will complete 4 experimental in-person sessions. Following a phone-screen to assess preliminary eligibility, participants will come to the study center for in-person baseline screening. This screening consists of a urine toxicology screen, a breathalyzer test, and self-report questionnaires. The remaining three sessions will be completed in person which mainly consist of cross-cue reactivity sessions, self-report measures, and a qualitative exit interview following the final session.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Males/females who are 18 to 25 years of age
  • Young adults who currently smoke commercial tobacco cigarettes (≥1x weekly in the past 30 days and for the past six months)
  • Young adults who currently smoke marijuana (≥4 times in past 30 days and at least weekly on average for the last six months)
  • Participants must report purchasing their own tobacco and marijuana at least once in the past 6 months
  • Participants must speak, comprehend, and read English.

Exclusion criteria

  • Intention to quit marijuana or tobacco use in the next 30 days
  • Self-reported illicit drug or heavy episodic alcohol use on >20 days in the past month (excluding marijuana)
  • Individuals who are pregnant or breastfeeding
  • Positive saliva test for recent THC use
  • Breath alcohol level above 0 at any session.
  • Participants who exclusively roll their own tobacco cigarettes

Treatment and study plan

Cue Reactivity

Behavioral

Participants will be exposed to neutral followed by cannabis or tobacco cues in a fixed sequence while they answer questions about their subjective state. The cues will include everyday items (e.g., eraser) and cannabis-related items (e.g., lighter).

Primary outcomes

  1. Change in self-reported cannabis craving

    Time frame: Up to 40 days post-baseline session

    This study utilizes a structured cannabis cue exposure paradigm. During cue exposure, participants rate subjective craving on a scale from 0, "Not at all," to 10, "Extremely." Cannabis craving will be assessed following neutral cue exposure and then cannabis cue exposure. The primary outcome will be change in cannabis craving.

  2. Change in self-reported tobacco craving

    Time frame: Up to 40 days post-baseline session

    This study utilizes a structured tobacco cue exposure paradigm. During cue exposure, participants rate subjective craving on a scale from 0, "Not at all," to 10, "Extremely." Tobacco craving will be assessed following neutral cue exposure and then tobacco cue exposure. The primary outcome will be change in tobacco craving.

Study contacts

Contact information is provided by the study sponsor or research team.

Elizabeth Aston, PhD

CONTACT

[email protected]

401-863-6668

Sponsors and collaborators

Lead sponsor

Brown University

Other

Collaborators

  • National Cancer Institute (NCI)
  • National Institutes of Health (NIH)

Registry information

Acronym: MATEY

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Feb 9, 2026
Registry last updated
Mar 4, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.